NHI reimbursement for expensive drugs to assess its propriety.

Published: 2002-03-19 07:00:00

Updated: 2002-03-19 07:00:00

The Health Insurance Review Agency (HIRA) is now going to assess the propriety of the NHI reimbursement for expensive medications as the 2002 Review Project was already approved by the Central Review Commission and the MOHW especially over 8 subjects including the reimbursement for medications. C...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK